Every analyst call
Every public market call we’ve tracked, newest first. Filter by instrument, direction, grading status, analyst, firm, or sector — every combination is a shareable link.
Sentiment · Biocon Limited
Analysts lean bullish
24 analyst stances matching these filters · one per analyst
Trackable
18 · 17 bull / 0 neutral / 1 bear
Long-Horizon
none in window
Commentary
6 · 5 bull / 1 neutral / 0 bear
Bullish 91.7% (22)Neutral 4.2% (1)Bearish 4.2% (1)
Date range
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Axis Direct is bullish on Biocon, assigning a buy rating and a target of ₹485, citing robust earnings and growth prospec…” | ETMarkets AnalysisETMarkets.com | Biocon | PENDING | |
| “Recommends buying Biocon in the range of ₹345-₹350, targeting ₹370 with a stop-loss at ₹330. This is a near-term trading…” | Ganesh DongreAnand Rathi | Biocon | HIT | |
| “Bullish on Biocon, recommending a buy at CMP ₹426.8 with a target of ₹470 and a stop-loss at ₹405. The stock has confirm…” | Ajit MishraReligare Broking | Biocon | MISS | |
| “Axis recommends Biocon as a technical buy for May, targeting ₹427-448 (11.4% upside) from a buying range of ₹375-385, wi…” | Axis Securities AnalysisAxis Securities | Biocon | NOT TRIGGERED | |
| “Baliga is bullish on Biocon, identifying it as a top pick and a major beneficiary in the pharma sector. He notes a techn…” | Ambareesh BaligaIndependent | Biocon Limited | — | |
| “Nischal Maheshwari remains positive on Biocon, believing the proposed QIP will ease balance sheet pressure by funding th…” | Nischal MaheshwariIndependent | Biocon | — | |
| “Recommends buying Biocon at ₹410 for intraday trading, with a target of ₹432 and a stop loss at ₹400.” | Vaishali ParekhPrabhudas Lilladher | Biocon | NOT TRIGGERED | |
| “Bullish on Biocon, expecting another 10-15% upside from current levels, with a fair value close to ₹500. This outlook is…” | Nikhil RankaNuvama Asset Management | Biocon | — | |
| “Bullish on Biocon, which has rebounded strongly from an upward-sloping trendline and broken above its recent swing high …” | Rajesh PalviyaAxis Securities | Biocon | HIT | |
| “Bullish on Biocon for the short term (1-2 weeks), with a target price of ₹418 and a stop loss at ₹369. The stock has sho…” | Ajit MishraReligare Broking | Biocon | HIT | |
| “Bullish on Biocon (BIOCON), suggesting to go long above ₹385 with a target price of ₹379 and a stop loss at ₹393. The st…” | Raja VenkatramanNeoTrader | Biocon | — | |
| “Initiated coverage on Biocon with a 'Buy' rating and a target price of Rs 410, implying a 13% upside from the current ma…” | Motilal Oswal AnalysisMotilal Oswal Financial Services | Biocon | HIT | |
| “Recommends buying Biocon Ltd around ₹383, with a stop loss at ₹370 and a target price of ₹405 in the near term. The stoc…” | Ganesh DongreAnand Rathi | Biocon | MISS | |
| “Bullish on Biocon, recommending a buy at ₹398 with a stop loss at ₹390 for a near-term target price of ₹415. The stock s…” | Ganesh DongreAnand Rathi | Biocon | MISS | |
| “Recommends buying Biocon Ltd between ₹380-395, targeting ₹454 in two to three months with a stop loss at ₹368. The call …” | Marketsmith India AnalysisMarketsmith India | Biocon | MISS | |
| “Bullish on Biocon, recommending a buy with a target price of ₹404 and a stop loss at ₹366. The stock is retesting a brea…” | Chandan TapariaMotilal Oswal Financial Services Ltd | Biocon | MISS | |
| “Bullish on Biocon, recommending buying at current market price and on dips towards ₹370, with a target of ₹400. This is …” | CA Rudramurthy BVVachana Investments | Biocon | HIT | |
| “Recommends buying Biocon with a target of ₹390 and a stop loss at ₹374, indicating a short-term bullish outlook.” | Kunal BothraIndependent | Biocon | PENDING | |
| “Recommends buying Biocon at current market price, targeting an initial level of 400, with a stop loss at 365. This call …” | CA Rudramurthy BVVachana Investments | Biocon | — | |
| “Bullish on Biocon, recommending a buy with a target price of ₹395 and a stop loss at ₹360. The stock has broken out of a…” | Chandan TapariaMotilal Oswal Financial Services Ltd | Biocon | PENDING | |
| “Bullish on Biocon Ltd, recommending a buy above ₹363 and dips to ₹355, with a target price of ₹374-385 in 1 month. The c…” | Raja VenkatramanNeoTrader | Biocon | HIT | |
| “Recommends buying BIOCON above ₹363 and on dips to ₹355, with a stop loss at ₹353 and a target of ₹374-378 for July 2nd.…” | Raja VenkatramanNeoTrader | Biocon | PENDING | |
| “Bullish on Biocon for the next two to three weeks, targeting ₹385 with a stop loss at ₹332. The stock established a robu…” | Jigar S. PatelAnand Rathi Share and Stock Brokers | Biocon | MISS | |
| “HSBC maintains a 'buy' rating on Biocon shares, following a significant boost from a ₹4,500 crore Qualified Institutiona…” | HSBC AnalysisHSBC | Biocon | — | |
| “Bullish on Biocon, recommending a buy at ₹356 with a target of ₹385 and a stop-loss at ₹344. The stock has broken out of…” | Rupak DeLKP Securities | Biocon | MISS |
Page 1Next